Submitted by Anonymous (not verified) on 5 March 2026 - 15:25
Opinion/decision on a Paediatric investigation plan (PIP): Pombiliti, Cipaglucosidase alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000223351
Source:
